» Articles » PMID: 32838486

[Mechanism of DERL3 Affecting the Proliferation, Invasion and Metastasis of Lung Adenocarcinoma A549 Cells]

Overview
Date 2020 Aug 26
PMID 32838486
Citations 3
Authors
Affiliations
Soon will be listed here.
Abstract

Background: Derlin 3 (DERL3) is downregulated in colorectal cancer (CRC) samples. Its level is closely linked to lymphatic metastasis or distant metastasis rate in CRC patients. However, its biological behavior in lung adenocarcinoma were rarely reported. The aim of this study is to investigate the ectopic expression of DERL3 in lung adenocarcinoma tissues and its effect on the invasion and metastasis of lung adenocarcinoma A549 cell line to reveal the possible mechanism of invasion and metastasis of lung adenocarcinoma.

Methods: Lung adenocarcinoma microarray gene chip data included 3 cases of lymph node metastasis and 3 cases of lung adenocarcinoma tissue without lymph node metastasis. The GEDS and Kaplan-Meier plot queries the survival curve and expression level of DERL3. Western blot was used to detect the expression of DERL3 in lung adenocarcinoma cells. The efficiency of knockdown DERL3 gene was detected by Western blot assay. Transwell detected the number of cells passing through the basement membrane of the transwell. EDU assay detected cell proliferation ability. Western blot detected the expression of epithelial-mesenchymal transition related proteins E-cadherin and Vimentin.

Results: The microarray gene chip results showed that compared with lung adenocarcinoma tissues without lymph node metastasis, 1,314 mRNAs in lung adenocarcinoma tissues with lymph node metastasis were up-regulated, 400 mRNAs were down (P<0.05). The expression of DERL3 increased in lung adenocarcinoma (P<0.05). The results of survival curve showed that the lung cancer patients with high expression of DERL3 with poor prognosis (P<0.05). Western blot results indicated that plasmid transfection was successful. Knockdown of DERL3 suppressed the ability of proliferation, invasion and migration in A549 cells (P<0.05). After knockdown of DERL3, the expression level of Vimentin was decreased, while E-cadherin expression increased (P<0.05).

Conclusions: Knockdown of DERL3 inhibited the proliferation, invasion and metastasis of A549 cells.

Citing Articles

Identification of prognostic immune subtypes of lung squamous cell carcinoma by unsupervised consistent clustering.

Wang Y, Hou L, Yang M, Fan J, Wang Y, Sun L Medicine (Baltimore). 2023; 102(37):e35123.

PMID: 37713826 PMC: 10508570. DOI: 10.1097/MD.0000000000035123.


Integrated profiling of endoplasmic reticulum stress-related DERL3 in the prognostic and immune features of lung adenocarcinoma.

Lin L, Lin G, Lin H, Chen L, Chen X, Lin Q Front Immunol. 2022; 13:906420.

PMID: 36275646 PMC: 9585215. DOI: 10.3389/fimmu.2022.906420.


Development and validation of a prognosis prediction model based on 18 endoplasmic reticulum stress-related genes for patients with lung adenocarcinoma.

Shu L, Liu S, Tao Y Front Oncol. 2022; 12:902353.

PMID: 36110953 PMC: 9469654. DOI: 10.3389/fonc.2022.902353.

References
1.
Greenblatt E, Olzmann J, Kopito R . Derlin-1 is a rhomboid pseudoprotease required for the dislocation of mutant α-1 antitrypsin from the endoplasmic reticulum. Nat Struct Mol Biol. 2011; 18(10):1147-52. PMC: 3196324. DOI: 10.1038/nsmb.2111. View

2.
Nagy A, Lanczky A, Menyhart O, Gyorffy B . Validation of miRNA prognostic power in hepatocellular carcinoma using expression data of independent datasets. Sci Rep. 2018; 8(1):9227. PMC: 6003936. DOI: 10.1038/s41598-018-27521-y. View

3.
Nawshad A, LaGamba D, Polad A, Hay E . Transforming growth factor-beta signaling during epithelial-mesenchymal transformation: implications for embryogenesis and tumor metastasis. Cells Tissues Organs. 2005; 179(1-2):11-23. DOI: 10.1159/000084505. View

4.
Wang Y, Xu L, Thilmony R, You F, Gu Y, Coleman-Derr D . PIECE 2.0: an update for the plant gene structure comparison and evolution database. Nucleic Acids Res. 2016; 45(D1):1015-1020. PMC: 5210635. DOI: 10.1093/nar/gkw935. View

5.
Brhane Y, Yang P, Christiani D, Liu G, McLaughlin J, Brennan P . Genetic Determinants of Lung Cancer Prognosis in Never Smokers: A Pooled Analysis in the International Lung Cancer Consortium. Cancer Epidemiol Biomarkers Prev. 2020; 29(10):1983-1992. PMC: 7541720. DOI: 10.1158/1055-9965.EPI-20-0248. View